Kit for quantitatively detecting GFAP concentration in human serum by polystyrene microsphere
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 山东莱博生物科技有限公司
- Publication Date
- 2012-04-11
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a kit for quantitatively detecting the concentration of glial fibrillary acidic protein (GFAP) in serum, in particular to a kit for quantitatively detecting the concentration of glial fibrillary acidic protein (GFAP) in human serum by using anti-GFAP antibody-specifically coated polystyrene microspheres. GFAP concentration kit. Background technique
[0002] Epidemiological surveys show that cerebrovascular disease, heart disease, and malignant tumors constitute the three major causes of human death. Compared with developed countries in the West, the morbidity and mortality of cerebrovascular diseases in my country are significantly higher than those of cardiovascular diseases. It is estimated that there are about 2 million new stroke patients in the country every year; about 1.5 million patients die of stroke every year; the number of surviving patients is 6 million to 7 million, and 70% to 80% of the survivors are left with p...